FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: Clinical implications and limitations

Sabine Kayser, Mark J. Levis

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: Clinical implications and limitations'. Together they form a unique fingerprint.

Medicine & Life Sciences